Advertisement
Screener

PETMED EXPRESS, INC. (PETS) Revenue from Contract with Customer, Including Assessed Tax

1.8 / 5 stars · 20/56 Roast Me

PETMED EXPRESS, INC. Revenue from Contract with Customer, Including Assessed Tax

PETMED EXPRESS, INC. (PETS) reported Revenue from Contract with Customer, Including Assessed Tax of $281.06 million for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-14.

Discontinued › Income Statement › Revenue

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2024-06-14

  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-03-31 was $66.50M, a 6.56% increase year-over-year.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2023-12-31 was $65.32M, a 10.95% increase year-over-year.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2023-09-30 was $71.00M, a 8.79% increase year-over-year.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2023-06-30 was $78.24M, a 11.71% increase year-over-year.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $281.06M, a 9.54% increase from fiscal 2023.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $256.58M, a 5.77% decline from fiscal 2022.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for fiscal 2022 was $272.28M, a 10.31% decline from fiscal 2021.
  • PETMED EXPRESS, INC. revenue from contract with customer, including assessed tax for fiscal 2021 was $303.58M, a 6.85% increase from fiscal 2020.
Period endRevenue from Contract with Customer, Including Assessed Tax 3 monthRevenue from Contract with Customer, Including Assessed Tax 3 month as first filedRevenue from Contract with Customer, Including Assessed Tax 6 monthRevenue from Contract with Customer, Including Assessed Tax 6 month as first filedRevenue from Contract with Customer, Including Assessed Tax 9 monthRevenue from Contract with Customer, Including Assessed Tax 9 month as first filedRevenue from Contract with Customer, Including Assessed Tax 12 monthRevenue from Contract with Customer, Including Assessed Tax 12 month as first filed
2024-03-31$66.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-14
$131.82M
derived: sum of 2 quarters · filed 2024-06-14
$202.82M
derived: sum of 3 quarters · filed 2024-06-14
$281.06M
10-K · filed 2024-06-14
2023-12-31$65.32M
10-Q · filed 2024-04-15
$136.32M
derived: sum of 2 quarters · filed 2024-04-15
$214.56M
10-Q · filed 2024-04-15
$276.97M
derived: sum of 4 quarters · filed 2024-06-14
2023-09-30$71.00M
10-Q/A · filed 2024-04-15
$149.24M
10-Q/A · filed 2024-04-15
$211.65M
derived: sum of 3 quarters · filed 2024-06-14
$270.52M
derived: sum of 4 quarters · filed 2024-06-14
2023-06-30$78.24M
10-Q/A · filed 2024-04-15
$140.65M
derived: sum of 2 quarters · filed 2024-06-14
$199.52M
derived: sum of 3 quarters · filed 2024-06-14
$264.78M
derived: sum of 4 quarters · filed 2024-06-14
2023-03-31$62.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-14
$121.28M
derived: sum of 2 quarters · filed 2024-06-14
$186.54M
derived: sum of 3 quarters · filed 2024-06-14
$256.58M
10-K · filed 2024-06-14
$256.86M
10-K · filed 2023-05-23
2022-12-31$58.87M
10-Q · filed 2024-04-15
$124.13M
derived: sum of 2 quarters · filed 2024-04-15
$194.17M
10-Q · filed 2024-04-15
$194.45M
10-Q · filed 2023-02-07
$260.02M
derived: sum of 4 quarters · filed 2024-04-15
2022-09-30$65.26M
10-Q/A · filed 2024-04-15
$65.39M
10-Q · filed 2022-11-08
$135.30M
10-Q/A · filed 2024-04-15
$135.58M
10-Q · filed 2022-11-08
$201.15M
derived: sum of 3 quarters · filed 2024-04-15
$261.73M
derived: sum of 4 quarters · filed 2024-04-15
2022-06-30$70.04M
10-Q/A · filed 2024-04-15
$70.19M
10-Q · filed 2022-08-02
$135.89M
derived: sum of 2 quarters · filed 2024-04-15
$196.47M
derived: sum of 3 quarters · filed 2024-04-15
$263.56M
derived: sum of 4 quarters · filed 2024-04-15
2022-03-31$65.85M
10-K/A · filed 2024-04-15
$66.00M
10-K · filed 2022-05-24
$126.42M
derived: sum of 2 quarters · filed 2024-04-15
$193.52M
derived: sum of 3 quarters · filed 2024-04-15
$272.28M
10-K · filed 2024-06-14
$273.42M
10-K · filed 2022-05-24
2021-12-31$60.57M
10-K/A · filed 2024-04-15
$60.72M
10-Q · filed 2022-02-04
$127.67M
derived: sum of 2 quarters · filed 2024-04-15
$207.41M
10-Q · filed 2023-02-07
$278.11M
derived: sum of 4 quarters · filed 2024-04-15
2021-09-30$67.10M
10-K/A · filed 2024-04-15
$67.39M
10-Q · filed 2021-11-02
$146.70M
10-Q · filed 2022-11-08
$217.54M
derived: sum of 3 quarters · filed 2024-04-15
$283.43M
derived: sum of 4 quarters · filed 2024-04-15
2021-06-30$78.76M
10-K/A · filed 2024-04-15
$79.31M
10-Q · filed 2021-07-30
$150.44M
derived: sum of 2 quarters · filed 2024-04-15
$216.34M
derived: sum of 3 quarters · filed 2024-04-15
$291.77M
derived: sum of 4 quarters · filed 2024-04-15
2021-03-31$71.68M
10-K · filed 2022-05-24
$137.57M
derived: sum of 2 quarters · filed 2022-05-24
$213.01M
derived: sum of 3 quarters · filed 2022-05-24
$303.58M
10-K/A · filed 2024-04-15
$309.21M
10-K · filed 2021-05-25
2020-12-31$65.90M
10-K · filed 2022-05-24
$141.33M
derived: sum of 2 quarters · filed 2022-05-24
$237.54M
10-Q · filed 2022-02-04
$311.82M
derived: sum of 4 quarters · filed 2022-05-24
2020-09-30$75.44M
10-K · filed 2022-05-24
$171.64M
10-Q · filed 2021-11-02
$245.93M
derived: sum of 3 quarters · filed 2022-05-24
$305.84M
derived: sum of 4 quarters · filed 2022-05-24
2020-06-30$96.20M
10-K · filed 2022-05-24
$170.49M
derived: sum of 2 quarters · filed 2022-05-24
$230.41M
derived: sum of 3 quarters · filed 2022-05-24
$300.34M
derived: sum of 4 quarters · filed 2022-05-24
2020-03-31$74.29M
10-K · filed 2021-05-25
$134.20M
derived: sum of 2 quarters · filed 2021-05-25
$204.14M
derived: sum of 3 quarters · filed 2021-05-25
$284.13M
10-K · filed 2022-05-24
2019-12-31$59.91M
10-K · filed 2021-05-25
$129.85M
derived: sum of 2 quarters · filed 2021-05-25
$209.84M
10-Q · filed 2021-01-26
$274.40M
derived: sum of 4 quarters · filed 2021-05-25
2019-09-30$69.94M
10-K · filed 2021-05-25
$149.92M
10-Q · filed 2020-11-03
$214.49M
derived: sum of 3 quarters · filed 2021-05-25
$274.56M
derived: sum of 4 quarters · filed 2021-05-25
2019-06-30$79.99M
10-K · filed 2021-05-25
$144.55M
derived: sum of 2 quarters · filed 2021-05-25
$204.62M
derived: sum of 3 quarters · filed 2021-05-25
$276.02M
derived: sum of 4 quarters · filed 2021-05-25
2019-03-31$64.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-25
$124.63M
derived: sum of 2 quarters · filed 2021-05-25
$196.03M
derived: sum of 3 quarters · filed 2021-05-25
$283.42M
10-K · filed 2021-05-25
2018-12-31$60.07M
10-Q · filed 2020-01-28
$131.46M
derived: sum of 2 quarters · filed 2020-01-28
$218.85M
10-Q · filed 2020-01-28
$286.18M
derived: sum of 4 quarters · filed 2020-05-26
2018-09-30$71.40M
10-Q · filed 2019-10-30
$158.79M
10-Q · filed 2019-10-30
$226.11M
derived: sum of 3 quarters · filed 2020-05-26
$286.22M
derived: sum of 4 quarters · filed 2020-05-26
2018-06-30$87.39M
10-Q · filed 2019-07-30
$154.71M
derived: sum of 2 quarters · filed 2020-05-26
$214.82M
derived: sum of 3 quarters · filed 2020-05-26
$281.53M
derived: sum of 4 quarters · filed 2020-05-26
2018-03-31$67.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-26
$127.43M
derived: sum of 2 quarters · filed 2020-05-26
$194.14M
derived: sum of 3 quarters · filed 2020-05-26
$273.80M
10-K · filed 2020-05-26
2017-12-31$60.11M
10-Q · filed 2019-01-29
$126.82M
derived: sum of 2 quarters · filed 2019-01-29
$206.48M
10-Q · filed 2019-01-29
2017-09-30$66.71M
10-Q · filed 2018-10-30
$146.37M
10-Q · filed 2018-10-30
2017-06-30$79.66M
10-Q · filed 2018-07-31
2017-03-31$249.18M
10-K · filed 2019-05-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVS HEALTH Corp (CVS)United States$108.783B27.06